| irbesartan |
AGTR1 |
1.76 |
osteosarcoma of bone; childhood osteosarcoma;
osteoarthritis |
(114, 115) |
| SLC10A1 |
4.73 |
hepatitis B |
(119) |
| AGT |
1.11 |
childhood osteosarcoma |
(41) |
| EDN1 |
0.79 |
carcinogenesis |
(120) |
| APOB |
0.5 |
carcinogenesis |
(121) |
| APOE |
0.47 |
Alzheimer’s
Disease |
(122) |
| ACE |
0.2 |
osteoporosis |
(123) |
| JUN |
0.3 |
osteosarcoma |
(124) |
| SLC2A4 |
0.22 |
osteosarcoma
of bone; childhood osteosarcoma |
(125) |
| CYP2C9 |
0.04 |
ankylosing spondylitis |
(126) |
| ambenonium |
ACHE |
9.19 |
Alzheimer’s disease |
(113) |
| sulfinpyrazone |
SLC22A12 |
2.37 |
renal hypouricemia |
(127) |
| ABCC1 |
0.88 |
Ewing’s sarcoma of bone osteosarcoma of
bone; childhood
osteosarcoma |
(87, 88) |
| ABCC2 |
0.79 |
sarcoma, fibrosarcoma |
(86) |
| FPR1 |
0.59 |
carcinogenesis |
(128) |
| UGT1A9 |
0.5 |
carcinoma |
(129) |
| NR1I2 |
0.1 |
osteosarcoma of bone; adolescent
idiopathic scoliosis |
(110, 111) |
| CYP3A4 |
0.02 |
osteosarcoma |
(96) |
| VDR |
0.01 |
osteoporosis |
(130) |
| HPGD |
0.02 |
carcinogenesis |
(131) |
| forasartan |
AGTR1 |
8.91 |
osteosarcoma
of bone; childhood osteosarcoma; osteoarthritis,
knee |
(114, 115) |
| tasosartan |
AGTR1 |
5.01 |
osteosarcoma of bone; childhood osteosarcoma;
osteoarthritis,
knee |
(114, 115) |
| AGTR2 |
7.1 |
hypertensive
disease |
(132) |
| pranlukast |
RNASE3 |
20.29 |
Ewing’s sarcoma of bone; osteosarcoma
of bone; deformity
of bone |
(116−118) |
| CYSLTR1 |
6.09 |
carcinogenesis; adenocarcinoma |
(133) |
| IL5 |
6.09 |
asthma |
(134) |
| MUC2 |
6.09 |
carcinoma, signet ring cell |
(135) |
| CYSLTR2 |
1.01 |
carcinogenesis |
(136) |
| TNF |
0.37 |
rheumatoid
arthritis |
(137) |
| NFKB1 |
0.25 |
osteosarcoma |
(138) |
